Pinnacle Financial Partners (Tennessee)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$13.7M Sell
48,399
-10,351
-18% -$3M 0.33% 84
2025
Q2
$16.4M Sell
58,750
-360
-0.6% -$102K 0.35% 80
2025
Q1
$18.3M Sell
59,110
-323
-0.5% -$95.4K 0.37% 71
2024
Q4
$15.6M Buy
59,433
+1,479
+3% +$439K 0.32% 83
2024
Q3
$18.7M Buy
57,954
+532
+0.9% +$174K 0.38% 73
2024
Q2
$17.9M Sell
57,422
-96
-0.2% -$28.2K 0.38% 69
2024
Q1
$16.4M Buy
57,518
+201
+0.4% +$58.8K 0.35% 76
2023
Q4
$16.5M Sell
57,317
-389
-0.7% -$106K 0.39% 69
2023
Q3
$15.5M Buy
57,706
+1,361
+2% +$340K 0.4% 68
2023
Q2
$12.5M Sell
56,345
-117
-0.2% -$27.1K 0.31% 89
2023
Q1
$13.6M Sell
56,462
-5,824
-9% -$1.43M 0.37% 81
2022
Q4
$16.4M Buy
62,286
+6,180
+11% +$1.66M 0.47% 63
2022
Q3
$12.6M Sell
56,106
-1,961
-3% -$475K 0.46% 69
2022
Q2
$14.1M Sell
58,067
-93
-0.2% -$22.8K 0.5% 61
2022
Q1
$14.1M Sell
58,160
-575
-1% -$132K 0.45% 64
2021
Q4
$13.2M Sell
58,735
-28,836
-33% -$6.09M 0.41% 72
2021
Q3
$18.6M Buy
87,571
+3,476
+4% +$800K 0.66% 41
2021
Q2
$20.5M Buy
84,095
+1,962
+2% +$483K 0.83% 30
2021
Q1
$20.4M Buy
82,133
+19,439
+31% +$4.64M 0.92% 28
2020
Q4
$14.4M Sell
62,694
-10,331
-14% -$2.38M 0.71% 40
2020
Q3
$18.6M Buy
73,025
+9,197
+14% +$2.28M 1.01% 22
2020
Q2
$15.1M Buy
63,828
+16,992
+36% +$3.88M 0.86% 27
2020
Q1
$9.5M Buy
46,836
+1,947
+4% +$425K 0.66% 37
2019
Q4
$10.8M Buy
44,889
+2,449
+6% +$540K 0.67% 45
2019
Q3
$8.21M Buy
42,440
+2,117
+5% +$406K 0.59% 53
2019
Q2
$7.43M Sell
40,323
-1,118
-3% -$200K 0.56% 52
2019
Q1
$7.87M Buy
41,441
+2,848
+7% +$544K 0.63% 47
2018
Q4
$7.51M Buy
38,593
+2,224
+6% +$434K 0.71% 43
2018
Q3
$7.54M Buy
36,369
+633
+2% +$125K 0.63% 45
2018
Q2
$6.6M Buy
35,736
+2,736
+8% +$484K 0.63% 46
2018
Q1
$5.63M Sell
33,000
-7,309
-18% -$1.34M 0.57% 47
2017
Q4
$7.01M Buy
40,309
+3,845
+11% +$680K 0.74% 35
2017
Q3
$6.8M Sell
36,464
-1,605
-4% -$284K 0.87% 30
2017
Q2
$6.56M Buy
38,069
+5,226
+16% +$850K 0.93% 28
2017
Q1
$5.39M Buy
32,843
+947
+3% +$157K 1.06% 24
2016
Q4
$4.66M Buy
31,896
+2,663
+9% +$401K 1.01% 28
2016
Q3
$4.8M Sell
29,233
-92
-0.3% -$15.6K 1.08% 25
2016
Q2
$4.69M Buy
29,325
+2,098
+8% +$326K 1.08% 25
2016
Q1
$4.08M Buy
27,227
+10,341
+61% +$1.54M 1.05% 27
2015
Q4
$2.74M Sell
16,886
-3,808
-18% -$599K 0.85% 31
2015
Q3
$2.86M Buy
20,694
+800
+4% +$126K 0.9% 35
2015
Q2
$3.05M Sell
19,894
-452
-2% -$72.4K 0.97% 31
2015
Q1
$3.25M Sell
20,346
-515
-2% -$81.1K 1.09% 27
2014
Q4
$3.32M Buy
20,861
+401
+2% +$62.5K 1.16% 23
2014
Q3
$2.87M Buy
20,460
+285
+1% +$37.2K 1.1% 30
2014
Q2
$2.39M Buy
20,175
+1,633
+9% +$189K 0.95% 37
2014
Q1
$2.29M Buy
18,542
+168
+0.9% +$20.4K 1.02% 35
2013
Q4
$2.1M Sell
18,374
-3,510
-16% -$399K 0.96% 41
2013
Q3
$2.45M Buy
21,884
+9
+0% +$976 1.22% 33
2013
Q2
$2.16M Buy
+21,875
New +$2.27M 1.12% 40

Other funds holding AMGN

Pinnacle Financial Partners (Tennessee)'s AMGN Position: Q3 2025 in Review

Pinnacle Financial Partners (Tennessee) reduced its Amgen (AMGN) stake by 18% in Q3 2025, selling an estimated $3M and leaving 48,399 shares worth $13.7M. The position accounts for 0.33% of the portfolio, ranked #84.

Pinnacle Financial Partners (Tennessee) first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $20.5M in Q2 2021. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Pinnacle Financial Partners (Tennessee) held 48,399 shares of Amgen worth $13.7M as of Q3 2025.
  • Pinnacle Financial Partners (Tennessee) sold 10,351 Amgen shares in Q3 2025, an estimated $3M.
  • Amgen made up 0.33% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #84 holding.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
  • Pinnacle Financial Partners (Tennessee)'s Amgen position peaked at $20.5M in Q2 2021.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.